Synthetic peptide analogs derived from bcr/abl fusion proteins induce heteroclitic human T cell responses.
Yasukawa
Masaki
M
The first Department of Internal Medicine, Ehime University School of Medicine, Japan. yasukawa@m.ehime-u.ac.jp
D016044:Fusion Proteins, bcr-abl / Q000138:chemical synthesis* / Q000502:physiology*; D016313:Genes, abl / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000502:physiology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism
D010446:Peptide Fragments; D016044:Fusion Proteins, bcr-abl